Background-Pregnant women with congenital heart disease (CHD) are susceptible to cardiovascular, obstetric, and offspring complications. In women with CHD, cardiac dysfunction may compromise uteroplacental flow and contribute to the increased incidence of obstetric and offspring events. Methods and Results-We performed a prospective multicenter cohort study of pregnant women with CHD and healthy pregnant women. We compared clinical, laboratory, echocardiographic, and uteroplacental Doppler flow (UDF) parameters at 20 and 32 weeks gestation, and pregnancy outcome. We related cardiovascular parameters to UDF parameters and pregnancy outcome in women with CHD. We included 209 women with CHD and 70 healthy women. Cardiovascular parameters (N-terminal pro-B-type natriuretic peptide, left and right ventricular function) differed between both groups. UDF parameters were impaired in CHD women (umbilical artery pulsatility and resistance index at 32 weeks in CHD versus healthy women, P=0.0085 and P=0.017). The following cardiovascular parameters prepregnancy and at 20 weeks gestation were associated with UDF (umbilical artery resistance index) at 32 weeks at multivariable analysis: (1) right ventricular function (tricuspid annular plane systolic excursion) (P=0.002), (2) high N-terminal pro-B-type natriuretic peptide (P=0.085), (3) systemic (P=0.001), and (4) pulmonary (P=0.045) atrioventricular valve regurgitation. Women with CHD had more obstetric (58.9% versus 32.9%, P<0.0001) and offspring events (35.4% versus 18.6%, P=0.008) than healthy women. Impaired UDF was associated with adverse obstetric and offspring outcome. Conclusions-UDF parameters are abnormal in pregnant women with CHD. Cardiovascular function is associated with an abnormal pattern of UDF. Compromised UDF may be a key factor in the high incidence of offspring and obstetric complications in this population.
C ongenital heart disease (CHD) occurs in ≈1% of newborns, and 50% of these children are female. The extensive evolution of cardiac surgery for CHD has resulted in a large population of adult women with CHD. Many of them pursue pregnancy. Pregnancy in these women is associated with cardiovascular complications, which occur in ≈10% of pregnancies. Moreover, obstetric and offspring complications are also more prevalent than in healthy pregnant women. [1] [2] [3] [4] [5] In women with CHD, offspring complications are related to maternal cardiac function. 5 However, the underlying pathophysiology of this relationship is not completely unraveled. In healthy women with intrauterine growth restriction or hypertensive disorders of pregnancy, the process of placentation is often disturbed, resulting in abnormal uterine and umbilical artery Doppler flow patterns. 6 Such abnormal uteroplacental Doppler flow (UDF) patterns are validated markers of adverse offspring outcome. Moreover, coexisting maternal cardiac and
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vascular function abnormalities have been demonstrated. [7] [8] [9] Whether these abnormalities may be explained by damage caused by circulating angiogenic factors secreted by the placenta, or abnormal placentation and offspring outcome are caused by (subtle) underlying cardiac and vascular disease, is unknown. In women with CHD, the relation between cardiac function (as expressed in N-terminal pro-B-type natriuretic peptide [NT-proBNP] levels and echocardiographic parameters), UDF patterns, and offspring complications has not been investigated. We hypothesized that preexisting cardiac dysfunction in pregnant women with CHD results not only in cardiovascular complications, but also can lead to disturbed placentation with abnormal UDF patterns, thus compromising normal growth and development of the fetus and contributing to offspring complications in pregnancy. To confirm this hypothesis, we performed a prospective study in women with CHD and healthy women. The primary objectives of this study are (1) to compare the cardiovascular clinical, biochemical, and echocardiographic parameters, and UDF patterns, as well, of pregnant women with CHD with healthy pregnant women, and (2) to relate maternal cardiovascular parameters in women with CHD to UDF patterns. The secondary objective is to relate UDF patterns to obstetric and offspring outcome. This study will give insight in the pathophysiology of offspring complications in women with CHD.
Patients and Methods

Design and Setting
This prospective observational multicenter cohort study was conducted between March 2008 and August 2011. The extensive study design of the Zwangerschap en Aangeboren HARtAfwijkingen (ZAHARA) II study was published previously and is summarized below.
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Patient Selection
Female patients with structural CHD (aged ≥18 years) reporting pregnancy with a duration ≤20 weeks who provided written informed consent and who were followed in 1 of the 8 participating tertiary hospitals participated in the study. In the Netherlands, pregnancies of all healthy women are routinely handled by midwives, regardless of socioeconomic status. Therefore, simultaneously, healthy pregnant women were recruited from midwifery practices. Miscarriages or termination before 20 weeks gestation and twin pregnancies were excluded, as were women with known illicit drug or alcohol abuse. The study was approved by the Medical Ethics Committee of all participating hospitals.
Sample Size Calculation
One of the primary aims of the ZAHARA II study was to compare the UDF, expressed as pulsatility and resistance indices in the uterine and umbilical artery, during pregnancy between women with CHD and healthy controls. A total sample size of 240 subjects (160 patients and 60 [healthy] controls) achieves 80% power to detect a difference of 0.05 in pulsatility index (25% of the expected standard deviation) among the means versus the alternative of equal means by using an independent samples t test with a 0.05 significance level. The common standard deviation within a group is assumed to be 0.20. The sample size for comparison of pulsatility index (PI) was based on an effect size of 0.25. For resistance index (RI), we would use the same assumption and therefore arrive at a similar sample size.
Preconception Characteristics
Baseline data were recorded at the first prenatal visit and included maternal age, obstetric history, cardiovascular history, comorbidity, prepregnancy cardiac status and echocardiographic recordings (including systemic and pulmonary ventricular function and valvular function), use of medication, and alcohol and smoking history.
Evaluation at 20 and 32 Weeks
At 20 and 32 weeks gestation, participants underwent clinical and laboratory evaluation (including serum hemoglobin and NT-proBNP), echocardiographic examination, and UDF registration (PI and RI of the umbilical artery and of the right and left uterine artery, and the presence of early diastolic notching). All echocardiographic recordings were made on commercially available Philips or Vingmed General Electric ultrasound equipment. Echocardiograms were evaluated off-line by 3 experienced cardiologists (each of them reviewed a part of the echocardiograms). A fourth cardiologist checked the consistency and accuracy of the echocardiography data. Chamber quantification and ventricular and valvular function were assessed according to current guidelines. [11] [12] [13] [14] Because Tricuspid Annular Plane Systolic Excursion (TAPSE) and ejection fraction by Simpsons rule are not validated in patients with single ventricles and systemic right ventricles, these measurements were not performed in these patient groups.
Obstetric and Offspring Events
Extensive definitions of obstetric and offspring events were published previously and are summarized below. 10 Obstetric events were noncardiac death, pregnancy-induced hypertension, preeclampsia, eclampsia, gestational diabetes mellitus, HELLP syndrome (hemolysis, elevated liver enzymes, low platelet syndrome), hyperemesis gravidarum, assisted delivery, postpartum hemorrhage, preterm labor, preterm premature rupture of membranes, and abruptio placentae.
Offspring events were fetal death, neonatal death, intraventricular hemorrhage, neonatal respiratory distress syndrome, infections leading to hospital admission, neonatal intensive care unit admission, premature birth, occurrence of CHD, occurrence of other congenital disease, small for gestational age, and low birth weight.
Statistical Analysis
We used SPSS (IBM SPSS Statistics, version 19.0, IBM SPSS Statistics, IBM Corporation, Armonk, NY) and STATA (version 12.0, StatCorp LP, College Station, TX) for statistical analysis. Continuous variables with normal distribution are presented as mean with standard deviation (±standard deviation), nonnormally distributed variables as median with interquartile ranges, and dichotomous variables are presented as absolute numbers with percentages. Cardiovascular parameters and UDF parameters at 20 and 32 weeks gestation, and pregnancy outcome, were compared between women with CHD and healthy women. Comparison of continuous variables between groups was performed with the Student t test or Mann-Whitney U test, depending on distribution, with and without logarithmic transformation. Longitudinal comparison of continuous variables within CHD and healthy pregnancy groups at 2 time points (20 and 32 weeks) was performed by using the paired t test. We compared the PI and RI within the groups CHD and healthy women and compared these measurements of the CHD group with measurements of healthy women at 20 weeks and at 32 weeks, as well. For the comparison of dichotomous variables, we used the χ 2 test or Fisher exact test, as appropriate. A P value of <0.05 was considered statistically significant and all P values are 2-sided. Uni-and multivariable linear and logistic regression analyses were performed to assess associations between cardiovascular parameters and UDF parameters during pregnancy and between UDF parameters and obstetric and offspring outcome, as well, in women with CHD. The following predefined variables were assessed in univariable analysis: age, disease complexity, 15 risk of cardiovascular complications according to modified World Health Organization class, 16 body surface area, body mass index, New York Heart Association functional class, resting heart rate, heart rhythm, mean arterial pressure, smoking during pregnancy, cardiac medication use, prepregnancy hypertension, anemia, high NT-proBNP, valve dysfunction (stenosis and regurgitation), left ventricular diastolic In addition, variables at 20 weeks gestation were adjusted for prepregnancy values that were significantly associated with the studied end points (P<0.05), and variables at 32 weeks gestation were adjusted for values that were significantly associated with the studied end points prepregnancy and at 20 weeks gestation. Variables that were strongly associated with the studied end points (P<0.10) or variables considered relevant (P>0.10) entered the multivariable model. The final multivariable model was constructed by backward deletion of the least significant characteristic, with a criterion for deletion of P≥0.10. When performing the multivariable model, we used pairwise deletion of cases to deal with missing values.
Results
Prepregnancy Baseline Characteristics
We recruited 234 pregnant women with CHD. Twenty-five women were excluded because of miscarriage (n=11), serious protocol violation (n=6), twin pregnancy (n=4), or withdrawal of informed consent (n=4). Simultaneously, 70 healthy, ageand parity-matched pregnant control women with a singleton pregnancy were recruited.
No significant difference was observed between women with CHD and healthy pregnant women with respect to maternal age at conception (28.7±4.4 versus 29.2±4.5, P=0.44), parity (64.1% versus 62.9% nulliparous, P=0.46), ethnic origin (95.7% versus 97.1% white, P=0.35), and prepregnancy body mass index (23.5±3.9 versus 23.1±3.9, P=0.56). More healthy women smoked prepregnancy than CHD women (33.3% versus 20.7%, P=0.03). None of the women had impaired glucose tolerance or hypertensive disorder of pregnancy at the time of recruitment. Table 1 shows prepregnancy cardiovascular data of the CHD cohort. None of the women had uncorrected cyanotic disease or SpO 2 <90%; mean oxygen saturation was 98.5±1.5% at 20 weeks gestation. Of patients with shunt lesions, 78% had a history of correction of the defect. Cardiac medication was used before pregnancy by 15.8% of women with CHD; 7.2% were on anticoagulation therapy and 12.4% used a β-blocker. Sinus rhythm was present in 88% (n=185). Systemic ventricular ejection fraction was known in 161 CHD women and was below 45% in 8.1% of these women. Prepregnancy right ventricular (RV) function (TAPSE) was known in 138 CHD women; RV dysfunction (TAPSE < 16 mm) existed in 14.5% of these women. Three In underlying heart disease, several groups are mentioned (ie, left sided lesions, right sided lesions, etc). The n and % in roman are then a % for such a group. Within each group, subdiagnoses are mentioned (ie, aortic stenosis, aortic coarctation, other). The n and % of subdiagnoses are shown in italics.
CHD indicates congenital heart disease; NYHA, New York Heart Association; and WHO, World Health Organization.
*Disease complexity: according to Warnes et al.
women conceived through intracytoplasmic sperm injection. Six women had a history of thyroid dysfunction; however, thyroidstimulating hormone was normal preconception.
Comparison of Cardiovascular and UDF Parameters Between Pregnant Women With CHD and Healthy Pregnant Women
New York Heart Association functional class deterioration >1 class at 32 weeks in comparison with prepregnancy occurred only in CHD and not in healthy women: 10.1% versus 0%, P=0.003. We compared laboratory, echocardiographic, and UDF parameters between CHD and healthy cohorts at 20 and 32 weeks gestation (Table 2) . NT-proBNP was higher throughout pregnancy in women with CHD and decreased during pregnancy in both groups; the decrease was significantly greater in CHD women (P=0.04). Systemic ventricular mass corrected for body surface area was higher and increased (P<0.005) only in women with CHD. Systemic ventricular ejection fraction did not change significantly in both groups. Several diastolic systemic ventricular function parameters were significantly worse in CHD women: systemic ventricular annular velocity (E′) was lower and diastolic filling pressure (E/E′) higher; change during pregnancy was comparable between both groups. RV systolic function (represented by BSA indicates body surface area; CHD, congenital heart disease; E, early passive filling velocity of systemic ventricular inflow; E′, early diastolic tissue Doppler velocity of systemic ventricular annular ring; E/A ratio, early to atrial mitral inflow velocity ratio; Hb, serum hemoglobin; LA, left atrium; MAP, mean arterial pressure; NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association functional class; Right ventricular S′, systolic tissue Doppler velocity of tricuspid annular ring; and TAPSE, tricuspid annular plane systolic excursion.
*Numbers different from n=209 or n=70 are shown separately. †Women with systemic right ventricle heart were only excluded from this specific analysis. ‡LA is the atrium receiving pulmonary venous flow; volume not measured in women with atrial correction of transposition and in Fontan patients. TAPSE and systolic annular velocity) was worse in CHD and decreased significantly in CHD women only (P=0.017 and P=0.009, respectively). Figure 1 shows UDF parameters at 20 and 32 weeks. Uterine and umbilical artery PI and RI were higher throughout pregnancy in the CHD group and decreased in both groups. Uterine artery PI and RI were both measured in 139 women at 20 weeks, and umbilical artery PI and RI were both measured in 157 women at 32 weeks, whereas 51 women did not have any uterine artery UDF measurement at 20 weeks, and 23 women did not have any of umbilical artery measurements at 32 weeks. Missing measurements were mainly attributable to logistic reasons.
Relation of Cardiovascular Parameters and UDF Indices in Women With CHD
We related maternal cardiovascular to UDF parameters. PI and RI were not both measured in all patients. Because results were comparable, we present RI data, in accordance with previous studies presenting data on the relation of UDF parameters with cardiac function in healthy women. 17 RI was available in 141 women for the uterine artery at 20 weeks gestation and in 157 women for the umbilical artery at 32 weeks. Univariable analysis revealed the following baseline (prepregnancy) variables to be associated with uterine artery RI (20 weeks): parity, preconception heart rate, systemic atrioventricular valve regurgitation, and left atrial volume. Heart rate, use of cardiac medication, and TAPSE at 20 weeks were also associated with uterine artery RI (20 weeks). Hypertension was not significantly associated with UDF in our cohort (B=0.028, P=0.28). Multivariable analysis rendered parity (B=0.04, P=0.048), resting heart rate at 20 weeks (B=−0.002, P=0.006), and use of cardiac medication at 20 weeks (B=0.08, P=0.035) significant. Univariable analysis and multivariable models for the prediction of umbilical artery RI (32 weeks) are presented in Tables 3 and 4 .
Pregnancy Outcome in CHD and Healthy Women and Relation of Outcome to UDF
Cardiovascular events occurred in 10.0% in the CHD and 0% in the healthy group. UDF parameters were not significantly associated with cardiovascular events.
Obstetric events occurred in 58.9% of CHD and 32.9% of healthy women (P<0.005). CHD women had more planned cesarean deliveries (13.4% versus 1.4%, P=0.003) and assisted vaginal deliveries (47.4% versus 25.7%, P=0.001). The secondary cesarean delivery rate did not differ between both groups (10.0% versus 11.4%). Several obstetric events occurred more often in CHD women without the differences reaching statistical significance: hypertensive disorders of pregnancy (17.7% versus 11.4%), preeclampsia (5.7% versus 1.4%), and preterm premature rupture of membranes (6.7% versus 2.9%). Postpartum hemorrhage occurred in both groups in 8.6%. In women with CHD, high umbilical artery RI (>90th percentile of healthy group) at 32 weeks was associated with obstetric events (P=0.049).
CHD women had shorter gestational age at delivery than healthy women (38.3 versus 39.7 weeks, P<0.005) and their babies had lower birth weight (3036 versus 3578 g, P<0.005). More babies of CHD women had an Apgar score of <9 (8.7% versus 0%, P=0.009) 10 minutes after birth.
Offspring events occurred more often in CHD women than in healthy women: 35.4% versus 18.6% (P=0.008); offspring events excluding the small number of women with isolated CHD in the offspring: 34.4% versus 18.6, P=0.012. More children of women with CHD were small for gestational age (16.3% versus 4.3%, P=0.008). Congenital heart disease occurred in 4.8% of offspring of CHD women versus 0% of healthy women's offspring (P=0.176). Offspring death occurred in 2.9% of the CHD group and 0% of the healthy group. Causes of death were pregnancy termination because of spina bifida or complex heart disease in 2 pregnancies, intrauterine death in 2 patients because of hydrops fetalis and placental insufficiency, and postpartum death because of respiratory insufficiency in 2 pregnancies. Premature birth occurred in 12.4% versus 5.7% (P=0.18). UDF patterns of women with CHD were associated with offspring events (Figure 2 ). This association was also significant when offspring CHD was excluded from the total number of offspring events.
Discussion
Our study is the first to compare UDF parameters of pregnant women with CHD and healthy pregnant women and to relate these to cardiovascular parameters in pregnant women with CHD.
Our data show that UDF and cardiovascular parameters differ between women with CHD and healthy women. In women with CHD, ventricular function, and valvular function, is related to UDF. As expected (because this is known in the general pregnant population), UDF is associated with obstetric and offspring events.
Adequate uteroplacental blood flow is necessary for normal pregnancy outcome. Vascular remodeling of the uteroplacental circulation guarantees sufficient blood flow throughout pregnancy. This remodeling is characterized by vascular widening of the uterine circulation, which is mediated by endovascular trophoblast invasion of uterine spiral arteries, increased shear stress, and angiogenic and humoral factors. 18 The remodeling process results in a low resistance in the uteroplacental circulation. Abnormalities in the placentation process can result in elevated resistance and pulsatility indices, which are associated with adverse maternal and offspring outcome, particularly hypertensive disorders and intrauterine growth restriction. 5, 19 In our study, women with CHD had significantly more obstetric and offspring complications than healthy women. This included a 4-fold increase in the incidence of preeclampsia and of children born small for gestational age. The increased incidence of these complications in women with CHD is in line with previous studies. For the full list of variables that were assessed in univariable analysis, see Methods. AV indicates atrioventricular; CI, confidence interval; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide; RI, resistance index; and TAPSE, tricuspid annular plane systolic excursion.
*Because the number of measurements of umbilical artery RI at 32 weeks is limited to 157, n cannot exceed this number.
†High NT-proBNP: >95th percentile of healthy controls (>128 ng/L). December 3/10, 2013
The association of abnormal UDF patterns and obstetric and offspring outcome, which is well established in the general population, was also present in our women with CHD. More important, UDF indices indicated a higher resistance in the uteroplacental circulation throughout pregnancy in women with CHD than in healthy women. We demonstrated that UDF abnormalities in women with CHD were related to cardiac function, both before and during pregnancy. Cardiac parameters associated with UDF in the multivariable model included preconception RV function but not left ventricular function. The likely explanation is the higher prevalence of RV dysfunction in our population. We used the TAPSE as a measure of RV function, because it is a reproducible simple measurement that is associated with RV function and symptoms in patients with CHD. 23, 24 Healthy pregnant women demonstrated a relatively high New York Heart Association functional class during pregnancy, reflecting the normal symptoms of pregnancy that can resemble heart failure. Functional class deteriorated more in women with CHD than in healthy women, which may indicate a less favorable adaptation of women with CHD to the hemodynamic changes of pregnancy.
Not surprisingly, NT-proBNP was higher throughout pregnancy in women with CHD than in healthy women. NT-proBNP decreased during pregnancy in both groups, as has been demonstrated previously in healthy women, 25 and as can be explained by an increasing glomerular filtration rate during pregnancy. We found elevated NT-proBNP to be weakly associated with abnormal UDF. NT-proBNP and BNP are well-established biomarkers of heart failure, and BNP is a predictor of maternal cardiovascular pregnancy complications. 26 NT-proBNP or BNP have not previously been investigated in relation to UDF in women with heart disease. Prepregnancy NT-proBNP was unfortunately not available. NT-proBNP may become a useful tool in pregnancy risk estimation in women with heart disease, but its role needs further investigation.
Cardiac medication was related to uterine artery RI. The use of cardiac medication is also a predictor of maternal cardiac complications and is probably a marker of disease severity. 5 Most medications were β-blockers, which are known to be associated with lower birth weight, which may be mediated by a negative effect on placental blood flow. Interestingly, both systemic and pulmonary atrioventricular valve regurgitation were associated with UDF parameters. Atrioventricular valve regurgitation is regarded as relatively harmless for the mother and her child, because the decrease in vascular resistance that accompanies pregnancy may reduce regurgitation. However, recent research indicates that mitral regurgitation does predict maternal cardiovascular complications and induces unfavorable cardiac remodeling. 5, 27 A recent study demonstrated that mitral prolapse is associated with preterm delivery. 28 Therefore, atrioventricular valve regurgitation cannot be regarded as completely innocent. Our results indicate that placental flow may be compromised by atrioventricular valve regurgitation. This association may be caused by a direct hemodynamic effect or by a common developmental disorder. Valve stenosis did not predict UDF, which might be explained by a lower prevalence than regurgitant lesions. In addition to cardiac parameters, parity, age, and smoking were also associated with UDF.
Our results support the hypothesis that prepregnancy cardiac dysfunction is related to UDF abnormalities, which are indicative of abnormal placentation. This finding is linked to the increased incidence of obstetric and offspring complications in women with CHD.
Evidence from the literature indicates a relationship in the general population between previous hypertension during pregnancy, preeclampsia, or intrauterine growth restriction and the later occurrence of acquired cardiovascular disease in the mother. [29] [30] [31] A recent study revealed an association of uterine artery RI during pregnancy with prepregnancy uterine artery blood flow. 32 Based on these data, it has been hypothesized that pregnancy complications, particularly preeclampsia and intrauterine growth restriction, reveal latent cardiovascular abnormalities that may already be present before pregnancy. Our study adds evidence to support this hypothesis, because, in our women with CHD, cardiac function prepregnancy is related to abnormal UDF and adverse offspring outcome.
Strengths and Limitations
Our study is the first to investigate UDF in pregnant women with cardiac disease. Several limitations must be considered. We designed our study to include pregnant women with various underlying congenital cardiac diseases. The heterogeneity of our population may have caused underrepresentation not only of individual diseases, but also of specific cardiac dysfunctions. This may have impacted the robustness of our prediction models. Moreover, because the study included women when they were already pregnant, collection of prepregnancy Figure 2 . Relation of uteroplacental Doppler flow parameters and offspring outcome. A, Uterine and umbilical artery PI and offspring events. B, Uterine and umbilical artery RI and offspring events. C, Uterine artery early diastolic notch and offspring events. Reported are the percentage of offspring events within, respectively, the groups uterine artery PI and RI at gestational week 20 and the groups umbilical artery PI and RI at gestational week 32, and within the groups with and without early diastolic notch. CI indicates confidence interval; EDN, early diastolic notch; OR, odds ratio; PI, pulsatility index; RI, resistance index; RR, relative risk; Uma, umbilical artery; and Uta, uterine artery. December 3/10, 2013 data was retrospective, and missing data were inevitable (mainly prepregnancy echocardiography data).
Additionally, in this multicenter study, deviation from the protocol sometimes occurred, whereas complex disease often prevented accurate measurements of chamber size and function. Cardiac output could therefore not be measured reliably, and not all data were available in all patients. Technical limitations prevented the digital storage of UDF patterns, which were therefore measured by the different caregivers. Our composite outcome variable combined all offspring events. Because some offspring events (eg, CHD) may not be influenced by UDF or may be influenced through a different mechanism, we repeated the analysis without offspring CHD, which did not significantly alter outcome. We did not have data available on the course of intrauterine growth and could not report on intrauterine growth restriction. Therefore, we used small for gestational age as a parameter of offspring growth. There might be some inclusion bias because we did not include patients from regional hospitals. Because the composition of our population is comparable with the Dutch national congenital database (CONCOR), this bias can be regarded unimportant. Because of the significant number of missing data from echocardiography in the preconception period, we chose to make a prediction model by using data at 20 weeks gestation. Where possible, we assessed the influence of the known prepregnancy data. Despite these limitations, we were able to demonstrate that cardiac function in women with CHD is associated with an abnormal pattern of UDF and adverse pregnancy outcome. Our study results lead to an improved understanding of the pathophysiology of offspring events in women with CHD, and may also contribute to a better insight in the pathophysiology of offspring complications in the general population.
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